Assignee
ATOGEN CO LTD
KR·5 granted patents·3 pending applications·2 citations·filing 2015–2025
Top patents by PatentIndex Score
8 records- 0182US11318178B2Lactobacillus reuteri ATG-F4 strain having function of enhancing dopamine secretion and pharmaceutical composition comprising same for prevention or treatment of psychopathyATOGEN CO LTD·Filed 2019·Granted May 3, 2022·2 cites·3 claims
- 0268US12157882B2Lactobacillus plantarum strain ATG-K2, ATG-K6 or ATG-K8, and composition for preventing or treating vaginitis comprising sameATOGEN CO LTD·Filed 2021·Granted Dec 3, 2024·0 cites·3 claims
- 0364US11447741B2Lactobacillus plantarum strain ATG-K2, ATG-K6 or ATG-K8, and composition for preventing or treating vaginitis comprising sameATOGEN CO LTD·Filed 2019·Granted Sep 20, 2022·0 cites·7 claims
- 0463US2025222049A1Composition for preventing or treating lipid-related metabolic diseases, comprising lactobacillus plantarum atg-k2 or atg-k6ATOGEN CO LTD·Filed 2025·Application pending·0 cites
- 0556US2023201282A1Composition for preventing or treating lipid-related metabolic diseases, comprising lactobacillus plantarum atg-k2 or atg-k6ATOGEN CO LTD·Filed 2021·Application pending·0 cites
- 0652US12514886B2Composition comprising Lactobacillus reuteri ATG-F4 for prevention or treatment of muscular disorderATOGEN CO LTD·Filed 2019·Granted Jan 6, 2026·0 cites·3 claims
- 0748US2022143112A1Novel bifidobacterium longum strain or cosmetic composition comprising sameATOGEN CO LTD·Filed 2019·Application pending·0 cites
- 0832US10405569B2Lanctobacillus plantarum HAC01 strain having anti-inflammatory efficacy and metabolic disease alleviating efficacy and use thereofATOGEN CO LTD·Filed 2015·Granted Sep 10, 2019·0 cites·18 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →